Peptide-responsive cell surface receptor

The term 'Peptide-responsive cell surface receptor' is a classification used in pharmacological databases to describe the targets of peptide-based drugs whose exact molecular binding sites are either not yet fully identified or involve a complex interplay of multiple cell surface proteins. This designation is frequently applied to immunomodulatory peptides, such as Glatiramer acetate, which may interact with Major Histocompatibility Complex (MHC) molecules and T-cell receptors simultaneously (AdisInsight, 2024). These putative receptors often belong to the G protein-coupled receptor (GPCR) superfamily or function as signaling scaffolds that mediate physiological responses like inflammation, cell growth, or metabolic regulation (PubMed, 2023). Because the specific receptor remains 'putative,' therapeutic development often focuses on downstream functional assays rather than high-throughput screening against a single purified protein. The lack of a defined target presents challenges for rational drug design and the prediction of off-target toxicities (StatPearls, 2024). In many cases, these targets are eventually resolved into specific receptors as research progresses, but the aggregate category remains useful for describing drugs with polypharmacological or poorly understood mechanisms of action.

Other names

Putative peptide receptorsUnidentified peptide-binding sitesPeptide-responsive receptorsUnknown peptide receptors

Agonism or modulation of unidentified or multiple cell surface receptors to induce intracellular signaling cascades.